Atzor Marie-Christin, Jung Luisa, Selaskowski Benjamin, Pensel Max, Lux Silke, Philipsen Alexandra, Braun Niclas, Guth Matthias
Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland.
Nervenarzt. 2025 Sep;96(5):451-457. doi: 10.1007/s00115-025-01855-1. Epub 2025 Aug 4.
Digital interventions for day-to-day use in adult attention deficit hyperactivity disorder (ADHD) can be a useful further treatment option in addition to established ADHD treatments.
This review of the literature presents the digital interventions for adults with ADHD in Germany that are currently available or in advanced development.
The aim is the identification and characterization of the digital interventions available for adult ADHD with a special focus on key features, modes of use, evidence achieved so far and maturity levels.
In total, six applications for adults with ADHD (attexis, AwareMe App, AwareMe Chatbot, hiFoon, NeuroNation MED, ORIKO) were identified. Clinical studies with initial proof of efficacy have already been carried out for some of the interventions, for the remainder clinical studies are planned or are currently being carried out.
One of the digital interventions is already available on prescription in Germany as so-called digital healthcare apps (digitale Gesundheitsanwendungen, DiGA). Other developers plan to seek regulatory approval in the near future. Innovation potential is seen particularly in the translation of existing applications into new languages and in the future integration of mobile sensing functions.
对于成人注意力缺陷多动障碍(ADHD)的日常数字干预,除了既定的ADHD治疗方法外,可能是一种有用的进一步治疗选择。
本文献综述介绍了德国目前可用或处于高级开发阶段的针对成人ADHD的数字干预措施。
目的是识别和描述可用于成人ADHD的数字干预措施,特别关注关键特征、使用模式、目前已取得的证据以及成熟度水平。
总共识别出六种针对成人ADHD的应用程序(attexis、AwareMe App、AwareMe Chatbot、hiFoon、NeuroNation MED、ORIKO)。一些干预措施已经进行了具有初步疗效证据的临床研究,其余的临床研究正在计划中或正在进行。
其中一种数字干预措施已在德国作为所谓的数字医疗应用程序(digitale Gesundheitsanwendungen,DiGA)凭处方提供。其他开发者计划在不久的将来寻求监管批准。创新潜力尤其体现在将现有应用程序翻译成新语言以及未来整合移动传感功能方面。